Myles Minter
Stock Analyst at William Blair
(2.64)
# 2,356
Out of 5,182 analysts
25
Total ratings
57.89%
Success rate
15.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Outperform | n/a | $14.28 | - | 3 | Feb 17, 2026 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | n/a | $2.19 | - | 2 | Feb 17, 2026 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $10.82 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $2.71 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $91.92 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.96 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.52 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $834.45 | - | 2 | Nov 1, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $8.90 | +697.75% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $54.59 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $439.18 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $342.57 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $4.81 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $310.94 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $74.87 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $131.59 | -11.85% | 1 | Feb 24, 2020 |
Korro Bio
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $14.28
Upside: -
Neumora Therapeutics
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $2.19
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $10.82
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.71
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $91.92
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.96
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.52
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $834.45
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $8.90
Upside: +697.75%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $54.59
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $439.18
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $342.57
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $4.81
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $310.94
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $74.87
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $131.59
Upside: -11.85%